MedPath
FDA Approval

Metaxalone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 2, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metaxalone(800 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

California Pharmaceuticals, LLC

California Pharmaceuticals, LLC

021420944

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

NDC Product Code
70332-330
Application Number
ANDA204770
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 2, 2018
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
HYDROGENATED CASTOR OILInactive
Code: ZF94AP8MEYClass: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 1NMA9J598YClass: ACTIBQuantity: 800 mg in 1 1
ALGINIC ACIDInactive
Code: 8C3Z4148WZClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath